0A8L
OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, includ… Read more
Market Cap & Net Worth: 0A8L (0A8L)
0A8L (LSE:0A8L) has a market capitalization of $231.12K ($231.12K) as of March 19, 2026. Listed on the LSE stock exchange, this UK-based company holds position #21931 globally and #400 in its home market, demonstrating a 60.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying 0A8L's stock price $24.00 by its total outstanding shares 9630 (9.63K).
0A8L Market Cap History: 2026 to 2026
0A8L's market capitalization history from 2026 to 2026. Data shows growth from $231.12K to $231.12K (0.00% CAGR).
0A8L Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how 0A8L's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 0A8L by Market Capitalization
Companies near 0A8L in the global market cap rankings as of March 19, 2026.
Key companies related to 0A8L by market ranking:
- Associated Alcohols & Breweries Ltd. (NSE:ASALCBR): Ranked #21922 globally with a market cap of $43.11 Million USD ( ₹3.73 Billion INR).
- Satellogic Inc. Warrant (NASDAQ:SATLW): Ranked #21923 globally with a market cap of $43.11 Million USD.
- IDEX Biometrics ASA (LSE:0MTP): Ranked #21932 globally with a market cap of $42.98 Million USD ( Nkr489.69 Million NOK).
- Shinsegae Food (KO:031440): Ranked #21933 globally with a market cap of $42.97 Million USD ( ₩62.92 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #21922 | Associated Alcohols & Breweries Ltd. | NSE:ASALCBR | $43.11 Million | ₹705.25 |
| #21923 | Satellogic Inc. Warrant | NASDAQ:SATLW | $43.11 Million | $0.49 |
| #21932 | IDEX Biometrics ASA | LSE:0MTP | $42.98 Million | Nkr10.70 |
| #21933 | Shinsegae Food | KO:031440 | $42.97 Million | ₩48500.00 |
0A8L Historical Marketcap From 2026 to 2026
Between 2026 and today, 0A8L's market cap moved from $231.12K to $ 231.12K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $231.12K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of 0A8L was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $231.12K USD |
| MoneyControl | $231.12K USD |
| MarketWatch | $231.12K USD |
| marketcap.company | $231.12K USD |
| Reuters | $231.12K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.